ADS Clinical Care Consensus Living Guideline for Specialist Assessment, Referral and Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease in People with Diabetes (June 2025)
Summary People with type 2 diabetes mellitus (T2DM) have increased risk of dysmetabolic liver disease and liver fibrosis, linked with increased morbidity and mortality. In recent years, non-invasive methods for